Altered regulation of cardiac muscle contraction by Troponin T mutations that cause familial hypertrophic cardiomyopathy

Björn C. Knollmann, James D. Potter

Research output: Contribution to journalReview article

49 Scopus citations

Abstract

Mutations in cardiac Troponin T (TnT) are responsible for approximately 15% of all cases of familial hypertrophic cardiomyopathy (FHC). This review summarizes recent data from in vitro assays, transgenic models and clinical studies on how TnT mutations alter the regulation of cardiac muscle contraction. Each TnT mutation has somewhat different effects on myofilament properties (increased myofilament Ca2+ sensitivity, decreased maximal force, decreased binding affinity to the thin filament, impaired pH-regulation). But when the in vitro data are correlated with the results from the transgenic models, essentially all mutations can be predicted to result in: (1) impaired relaxation, (2) reduced diastolic compliance, (3) reduced contractile reserve, (4) preserved systolic function under baseline conditions, and (5) cardiac dysfunction under inotropic stimulation. Thus, the alterations of myofilament function caused by TnT mutations likely play an important role in the pathogenesis of FHC.

Original languageEnglish (US)
Pages (from-to)206-212
Number of pages7
JournalTrends in Cardiovascular Medicine
Volume11
Issue number5
DOIs
StatePublished - Oct 20 2001

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Altered regulation of cardiac muscle contraction by Troponin T mutations that cause familial hypertrophic cardiomyopathy'. Together they form a unique fingerprint.

  • Cite this